Welcome to the Stanford Division of Hematology, a dynamic center for basic and translational research, clinical trials, patient care, and teaching. Our physicians, scientists, staff, and trainees collaborate to advance the understanding and treatment of hematologic cancers and non-malignant hematologic disorders, all with the goal of improving outcomes for our patients. In pursuit of this objective, we engage with the broader Stanford community to bring innovation and cutting-edge science to our efforts.

There has never been a more exciting time to be a hematologist! The pace of discovery coupled with rapid translation from laboratory to clinic is improving outcomes for patients. Our Division is proud of its strong roots in basic science and we are committed to bringing novel discoveries and therapies to our patients.

Our physicians have expertise in a broad range of hematologic disorders including acute and chronic leukemias, myeloproliferative neoplasms, myelodysplastic syndromes, multiple myeloma, amyloidosis, thrombotic diseases, coagulation disorders, and general hematology.

The basic and translational research efforts of our Division encompass a broad range of focus areas including stem cell biology, cancer and leukemia stem cells, telomere biology, myeloid malignancies, genomics and single-cell multi-omics, the microbiome, human organoids, vascular biology and the role of thrombin-cleaved osteopontin in coagulation and cancer.

Our passionate and dedicated faculty members have mentored and trained leaders in the field of hematology and are excited to inspire and guide the next generation of leading physicians and research scientists.

We invite you to learn more about us through our website.

Dr. Ann Mullally

Chief, Division of Hematology